Covid-19 man­u­fac­tur­ing roundup: In­dia starts man­u­fac­tur­ing of No­vavax vac­cine — re­port; US ships spare shots to Colom­bia

As In­dia’s sec­ond wave of Covid-19 in­fec­tions con­tin­ues to trend down­ward and sci­en­tists warn of a third wave of the pan­dem­ic that could lead to be­tween 200,000 and 500,000 new cas­es a day, the Serum In­sti­tute of In­dia (SII) has an­nounced the first batch of No­vavax’s vac­cine has been pro­duced, CEO Adar Poon­awal­la tweet­ed.

The shot could be cleared for use in In­dia by reg­u­la­tors be­tween Ju­ly and Sep­tem­ber, New Del­hi TV re­port­ed. That jab would mark the fifth one ap­proved for use in In­dia, as the coun­try strug­gles with a vac­ci­na­tion roll­out, fol­low­ing a mas­sive sec­ond wave of in­fec­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER